帕金森病认知障碍的诊断,评估和管理:系统性审查
Dana Pourzinal1, Charlotte Elgey1, Daniel X Bailey2
1The University of Queensland Centre for Clinical Research, Herston, Australia.
International psychogeriatrics
|May 13, 2025
概括
本综述强调了在帕金森病 (PD) 中诊断和管理认知障碍的变化. 在神经心理评估和非药物干预方面存在差距,需要更新PD认知障碍的临床指南.
科学领域:
- 神经学 神经学
- 神经科学是一个神经科学.
- 临床实践指南 临床实践指南
背景情况:
- 帕金森病 (PD) 的认知障碍在临床诊断,评估和管理方面表现出显著的变化.
- 目前的临床实践缺乏标准化的方法,影响了患者的护理.
- 需要对现有的指导方针和文献进行全面的审查,以告知临床决策.
研究的目的:
- 系统地审查和批判性地评估目前诊断,评估和管理帕金森病认知障碍的建议.
- 识别现有指南和文献中的不一致性和差距.
主要方法:
- 按照PRISMA的指导方针,对五个学术和五个灰色文献数据库 (PubMed,SCOPUS,Medline,PsycINFO,CINAHL) 进行系统搜索.
- 将指导方针和系统审查 (2003-2024) 纳入英语报告中,为PD的认知障碍提出建议.
- 使用AGREE-II和AMSTAR工具分别对包含的指南和审查进行质量评估.
主要成果:
- 包括32个指导方针和24个系统审查,质量从中等到高.
- 建议涵盖了PD认知障碍的诊断,神经心理评估,治疗和护理.
- 对于特定的认知工具,护理考虑和非药物干预措施,尽管有支持证据,但发现了有限的建议.
结论:
- 在PD认知障碍的神经心理评估过程中发现了显著的差距.
- 他们注意到对非药物干预的不一致的建议和有限的护理考虑.
- 对PD认知障碍的临床实践指南的未来代是必要的,以解决这些已识别的差距.
更多相关视频
07:26Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
Published on: September 26, 2019
08:36The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
Published on: July 28, 2022
相关概念视频
Neural Regulation
39.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.0K
Parkinson's Disease: Overview
342
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
342
Parkinson's Disease: Treatment
161
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
161
Alzheimer's Disease: Overview
342
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
342
Alzheimer's Disease: Treatment
133
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
133
Dementia
74
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
74
